Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders

Schizophrenia Bulletin

Volumn 32, Issue 3, 2006, Pages 464-473

  Drake, Robert E ^a   McHugo, Gregory J ^a   Xie, Haiyi ^a   Fox, Melinda ^a   Packard, Joan ^a   Helmstetter, Barbara ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Co occurring disorders; Dual diagnosis; Substance abuse

Indexed keywords

ARTICLE; COMORBIDITY; CONVALESCENCE; COPING BEHAVIOR; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; INSTITUTIONALIZATION; LIFE SATISFACTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SCHIZOPHRENIA; SOCIAL INTERACTION; SUBSTANCE ABUSE; SYMPTOM; TIME;

ADULT; BRIEF PSYCHIATRIC RATING SCALE; COMORBIDITY; CONVALESCENCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; UNITED STATES;

EID: 33745612036     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbj064     Document Type: Article

References (57)

1. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 1990;264:2511-2518.
2. Drake RE, Osher FC, Noordsy DL, Hurlbut SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull. 1990;16:57-67.
3. Duke PJ, Pantelis C, Barnes RE. South Westminster Schizophrenia Survey: alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry. 1994;164:630-636.
4. Mueser KT, Yarnold PR, Levinson DF, et al. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull. 1990;16:31-56.
5. Ziedonis D, Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr Bull. 1997;23:229-238.
6. Bowers MB, Mazure CM, Nelson CJ, Jatlow PI. Psychotogenic drug use and neuroleptic response. Schizophr Bull. 1990;16:81-85.
7. Swofford CD, Kasckow JW, Scheller-Gilkey G, Inderbitzin LB. Substance use: a powerful predictor of relapse in schizophrenia. Schizophr Res. 1996;20:145-151.
8. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Davis JM, Lewis DA. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry. 1995;152:856-861.
9. Cournos F, Empfield M, Horwath E, et al. HIV prevalence among patients admitted to two psychiatric hospitals. Am J Psychiatry. 1991;148:1225-1229.
10. Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001;91:31-37.
11. Bartels SJ, Drake RE, McHugo G. Alcohol abuse, depression, and suicidal behavior in schizophrenia. Am J Psychiatry. 1992;149:394-395.
12. Swartz MS, Swanson AJ, Hiday V, Borum R, Wagnor HR, Burns BJ. Violence and severe mental illness: the effects of substance abuse and non-adherence to medication. Am J Psychiatry. 1988;155:226-231.
13. Goodman LA, Salyers MP, Mueser KT, et al. Recent victimization in women and men with severe mental illness: prevalence and correlates. J Trauma Stress. 2001;14:615-632.
14. Abram K, Teplin L. Co-occurring disorders among mentally ill jail detainees: implications for public policy. Am Psychol. 1991;46:1036-1044.
15. Caton C, Shrout P, Eagle P, Opler L, Felix A, Dominguez B. Risk factors for homelessness among schizophrenic men: a case-control study. Am J Public Health. 1994;84:265-270.
16. Dixon L, McNary S, Lehman A. Substance abuse and family relationships of persons with severe mental illness. Am J Psychiatry. 1995;152:456-458.
17. Harding CM, Zubin J, Strauss JS. Chronicity in schizophrenia: fact, partial fact, or artifact? Hosp Community Psychiatry. 1987;38:477-486.
18. McGlashan TH. A selective review of recent North American long-term follow-up studies of schizophrenia. Schizophr Bull. 1988;14:515-542.
19. Simpson DD, Joe GW, Lehman WEK, Sells SB. Addiction careers: etiology, treatment, and 12-year follow-up procedures. J Drug Issues. 1986;16:107-121.
20. Vaillant GE. Natural History of Alcoholism Revisited. 2d ed. Cambridge, Mass: Harvard University Press; 1995.
21. Drake RE, Mueser KT, Clark RE, Wallach MA. The course, treatment, and outcome of substance disorder in persons with severe mental illness. Am J Orthopsychiatry. 1996;66:42-51.
22. Brunette MF, Mueser KT, Drake RE. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug Alcohol Rev. 2004;23:471-481.
23. Drake RE, Mueser KT, Brunette M, McHugo GJ. A review of treatments for people with severe mental illness and co-occurring substance use disorder. Psychiatr Rehabil J. 2004;27:360-374.
24. Mueser KT, Drake RE, Sigmon SC, Brunette M. Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: a review of specific interventions. J Dual Diagn. 2005;1:57-82.
25. Jacobson N. In Recovery: The Making of Mental Health Policy. Nashville, Tenn: Vanderbilt University Press; 2004.
26. Deegan PE. Recovery: the lived experience of rehabilitation. Psychosoc Rehabil J. 1988;11:11-19.
27. Ralph RO. Review of Recovery Literature: A Synthesis of a Sample of Recovery Literature, 2000. Alexandria, Va: National Technical Assistance Center for State Mental Health Planning; 2000.
28. New Freedom Commission on Mental Health. Achieving the Promise: Transforming Mental Health Care in America. Washington, DC: Dept of Health and Human Services; 2003.
29. Liberman RP, Kopelowicz A, Ventura J. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry. 2002;14:256-272.
30. Provencher HL, Gregg R, Mead S, Mueser KT. The role of work in the recovery of persons with psychiatric disabilities. J Psychiatr Rehabil. 2002;26:132-144.
31. Robinson DG, Woerner MB, McMeniman M, Mendelowitz A, Bilder RM. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2004;161:473-479.
32. Resnick SG, Rosenheck RA, Lehman AF. An exploratory analysis of correlates of recovery. Psychiatr Serv. 2004;55:540-547.
33. Alcoholics Anonymous. 3d ed. New York, NY: Alcoholics Anonymous World Services; 1976.
34. Galanter M, Kleber HD, eds. The American Psychiatric Publishing Textbook of Substance Abuse Treatment. 3d ed. Washington, DC: American Psychiatric Press; 2004.
35. Xie H, McHugo GJ, Helmstetter BS, Drake RE. Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders. Schizophr Res. 2005;75:337-348.
36. Drake RE, McHugo GJ, Clark RE, et al. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am J Orthopsychiatry. 1998;68:201-215.
37. Teague GB, Bond GR, Drake RE. Program fidelity in assertive community treatment: development and use of a measure. Am J Orthopsychiatry. 1998;68:216-232.
38. Spitzer RL, William JB, Gibbon M. Structured Clinical Interview for DSM III-R: Patient Version (SCID-P, 9/1/89 Version). New York, NY: Biometrics Research Deptment, New York State Psychiatric Institute; 1988.
39. Tessler R, Goldman H. The Chronically Mentally III: Assessing Community Support Programs. Cambridge, Mass: Ballinger; 1982.
40. Sobell MB, Maisto SA, Sobell LC, Copper AM, Sanders B. Developing a prototype for evaluating alcohol treatment effectiveness. In: Sobell LC, Sobell MB, Ward E, eds. Evaluating Alcohol and Drug Abuse Treatment Effectiveness. New York, NY: Pergamon; 1980:129-150.
41. McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved diagnostic instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis. 1980;168:26-33.
42. Clark RE, Ricketts SK, McHugo GJ. Measuring hospital use without claims: a comparison of patient and provider reports. Health Serv Res. 1996;31:153-169.
43. Lehman AF. A Quality of Life Interview for the chronically mentally ill. Eval Program Plann. 1988;51:51-62.
44. Lukoff D, Nuechterlein KH, Ventura J. Manual for expanded Brief Psychiatric Rating Scale (BPRS). Schizophr Bull. 1986;12:594-602.
45. McHugo GJ, Drake RE, Burton HL, Ackerson TH. A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. J Nerv Ment Dis. 1995;183:762-767.
46. Osher FC, Kofoed LL. Treatment of patients with psychiatric and psychopactive substance use disorders. Hosp Community Psychiatry. 1989;40:1025-1030.
47. Drake RE, Mueser KT, McHugo GJ. Clinician rating scales: Alcohol Use Scale (AUS) Drug Use Scale (DUS), and Substance Abuse Treatment Scale (SATS). In: Sederer LI, Dickey B, eds. Outcomes Assessment in Clinical Practice. Baltimore, Md: Williams and Wilkins; 1996:113-116.
48. Liang K, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
49. SAS Institute Inc. SAS/STAT User's Guide, Version 9. Cary, NC: SAS Institute Inc.; 2003.
50. Quimby E. Homeless clients' perspectives on recovery in the Washington, DC, Dual Diagnosis Project. Contemp Drug Problems. 1995;Summer:265-289.
51. Alverson H, Alverson M, Drake RE. An ethnographic study of the longitudinal course of substance abuse among people with severe mental illness. Community Ment Health J. 2000;36:557-569.
52. Strauss JS, Carpenter WT. The prediction of outcome in schizophrenia, II. Arch Gen Psychiatry. 1974;31:37-42.
53. Gurel L, Lorei TW. Hospital and community ratings of psychopathology as predictors of employment and readmission. J Consult Clin Psychol. 1972;39:286-291.
54. McHugo GJ, Drake RE, Teague GB, Xie H. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatr Serv. 1999;50:818-824.
55. Drake RE, Xie H, McHugo GJ, Green AI. The effects of clozapine on alcohol and drug use disorders among schizophrenic patients. Schizophr Bull. 2000;26:441-449.
56. Diener E. Subjective well-being: the science of happiness and a proposal for a national index. Am Psychol. 2000;55:34-43.
57. Drake RE, Essock SM, Shaner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv. 2001;52:469-476.